Connection
Stephen Dreskin to Anti-Allergic Agents
This is a "connection" page, showing publications Stephen Dreskin has written about Anti-Allergic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.729 |
|
|
|
-
Stitt JM, Dzieciatkowska M, Edwards MG, Hansen K, Hedlund G, Dreskin SC. The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders. Clin Exp Allergy. 2018 07; 48(7):898-901.
Score: 0.599
-
Stitt JM, Dreskin SC. The potential role of omalizumab in the treatment of chronic urticaria. Immunotherapy. 2014; 6(6):691-7.
Score: 0.111
-
Wood RA, Berger M, Dreskin SC, Setse R, Engler RJ, Dekker CL, Halsey NA. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics. 2008 Sep; 122(3):e771-7.
Score: 0.019